Neuronal ceroid lipofuscinoses therapeutic strategies: Past, present and future
Authors:
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (10) , 945-953
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosisBrain, 2006
- Murine Cathepsin F Deficiency Causes Neuronal Lipofuscinosis and Late-Onset Neurological DiseaseMolecular and Cellular Biology, 2006
- The CLN9 Protein, a Regulator of Dihydroceramide SynthaseJournal of Biological Chemistry, 2006
- Loss of the chloride channel ClC‐7 leads to lysosomal storage disease and neurodegenerationThe EMBO Journal, 2005
- Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variantAnnals of Neurology, 2004
- Adult‐onset Neuronal Ceroid Lipofuscinosis (Kufs Disease) with Autosomal Dominant Inheritance in AlabamaEpilepsia, 2003
- Neuronal Ceroid Lipofuscinoses Caused by Defects in Soluble Lysosomal Enzymes (CLN1 and CLN2)Current Molecular Medicine, 2002
- CLC‐3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosisGenes to Cells, 2002
- Tripeptidyl Peptidase I, the Late Infantile Neuronal Ceroid Lipofuscinosis Gene Product, Initiates the Lysosomal Degradation of Subunit c of ATP SynthaseThe Journal of Biochemistry, 2000
- Diagnosis and treatment of typical and atypical forms of lipopigment storage disordersAmerican Journal of Medical Genetics, 1988